tiletamine hydrochloride has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Csekes, E; Hunyadi, A; Račková, L; Vágvölgyi, M | 1 |
| Higashihara, M; Horie, R; Umezawa, K; Watanabe, M | 1 |
| Barak, V; Chowers, I; Dror, R; Lederman, M; Pe'er, J; Umezawa, K | 1 |
3 other study(ies) available for tiletamine hydrochloride and Malignant Melanoma
| Article | Year |
|---|---|
Protoflavones in melanoma therapy: Prooxidant and pro-senescence effect of protoapigenone and its synthetic alkyl derivative in A375 cells.
Topics: Antineoplastic Agents, Phytogenic; Autophagy; beta-Galactosidase; Biomarkers; Cell Cycle; Cell Line, Tumor; Cellular Senescence; Cyclohexanones; Ethers; Flavones; Humans; Hydroquinones; Melanoma; Reactive Oxygen Species; Superoxide Dismutase | 2020 |
Combined inhibition of NF-κB and Bcl-2 triggers synergistic reduction of viability and induces apoptosis in melanoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Cyclohexanones; Drug Synergism; Humans; Indoles; Melanoma; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Signal Transduction; Tumor Cells, Cultured | 2013 |
Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma.
Topics: Apoptosis; Benzamides; Blotting, Western; Caspase 3; Cell Proliferation; Cyclohexanones; Fluorescent Antibody Technique, Indirect; Humans; Imidazoles; Ki-67 Antigen; Liver Neoplasms; Melanoma; NF-kappa B; Quinoxalines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Uveal Neoplasms | 2010 |